INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Lisanti Capital Growth, LLC's Holding History (CIK: 0001424467)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 72,600 Value ($000) $6,064 Avg Close Range
Q3 2024
Shares 58,115 Value ($000) $4,252 Avg Close Range
Q2 2024
Shares 82,875 Value ($000) $5,676 Avg Close Range
Q1 2024
Shares 53,285 Value ($000) $3,687 Avg Close Range
Q4 2023
Shares 52,885 Value ($000) $3,788 Avg Close Range
Q2 2023
Shares 112,650 Value ($000) $7,133 Avg Close Range
Q1 2023
Shares 63,510 Value ($000) $3,439 Avg Close Range
Q4 2022
Shares 114,534 Value ($000) $6,061 Avg Close Range
Q3 2022
Shares 84,584 Value ($000) $3,936 Avg Close Range
Q2 2022
Shares 327,894 Value ($000) $18,716 Avg Close Range
Q1 2022
Shares 278,395 Value ($000) $17,035 Avg Close Range
Q2 2016
Shares 12,260 Value ($000) $476 Avg Close Range